Athersys

$1.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-6.81%) Today

+$0.03 (+1.69%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Athersys and other stocks, options, and ETFs commission-free!

About ATHX

Athersys, Inc. engages in the discovery and development of therapies designed to extend and enhance to quality of human life. It offers MultiStem as its stem cell product which provides biological potency and therapeutic effects for distinct diseases and conditions in the cardiovascular, neurological, inflammatory, and immune disease areas.

CEO

William B. J. Lehmann

Employees

Headquarters

Cleveland, Ohio

Founded

1995

Market Cap

371.10M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.56M

High Today

$1.90

Low Today

$1.77

Open Price

$1.90

Volume

1.66M

52 Week High

$3.59

52 Week Low

$1.53

ATHX Earnings

-$0.11

-$0.07

-$0.04

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours